Pharnext announces positive results from the pivotal Phase 3 trial of PXT3003 for the treatment of Charcot-Marie-Tooth disease type 1A
Also to be discovered
Carbios appoints four new Board members to strengthen international expertise in brand development, business growth and scientific research
Carbios strengthens its Board of Directors with Prof. Karine AUCLAIR, Sandrine CONSEILLER, Amandine DE SOUZA and Mateus SCHREINER GARCEZ LOPES
Interview of Philippe Pouletty by Hedwige Chevrillon in "Le Grand Journal de l'Éco" on BFM Business TV
"Radically innovative science solves environment and health issues"